• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

by Jasmine Pennic 08/25/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Mira, a hormonal health company, has launched Ultra4™, the first at-home hormone monitor to provide lab-quality insights.

– The new device tracks four key hormones—FSH, LH, E3G, and PdG—with a single wand and a 16-minute test. For the first time, people can monitor their entire cycle from home, from ovulation strength to hormonal balance, with the same precision previously available only in clinics.

Why Tracking Four Hormones Matters

Ultra4™’s technology tracks FSH, LH, E3G, and PdG simultaneously, providing a complete hormonal profile that adapts to each user’s unique biology. By tracking all four hormones across the entire cycle, not just the fertile window, Mira gives users a more complete picture of their hormonal health. This helps users spot irregularities, identify imbalances, monitor shifts over time, and understand their reproductive journey, whether they are trying to conceive, managing PCOS, or approaching menopause.

How Ultra4™ Delivers Lab-Quality Results at Home

Ultra4™ is the only tracker on the market powered by fluorescent technology, the same technology used in clinical laboratories. This gives the device up to seven times the accuracy of other fertility trackers on the market. It is also highly sensitive, capable of detecting subtle hormonal shifts that many other consumer devices miss. The device also offers users the flexibility to test any day of their cycle, or multiple times a day if needed, with guidance from Mira’s AI-powered app.

The product introduces new features, including:

  • 4D Ovulation Profiling™: Models the full hormonal ecosystem to assess when ovulation may occur and its viability.
  • Hormonal Fingerprint™: Creates a personalized baseline of a user’s hormone trends over time to help flag irregularities or early signs of perimenopause.
  • Egg Count Intelligence™: Tracks FSH daily to provide at-home insights into egg health and ovarian reserve.

“When we launched Mira, it was with a single hormone and a single goal: help women understand their fertility better,” said Sylvia Kang, CEO and Co-founder of Mira. “But users kept asking harder questions – about irregular cycles, missed ovulation, egg quality, hormonal balance. Ultra4 is our answer to those questions. It reflects everything we’ve learned in the past seven years from listening to our community.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Digital Health Funding Q3 2025: Choppy Undercurrents Beneath a Steady Surface

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |